MUC-1

1 abstract

Abstract
A combination of circulating tumor cell (CTC) and cancer stem cell (CSC) markers to predict the prognosis of breast cancer.
Org: Baylor College of Medicine Division of Hematology and Oncology, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Texas MD Anderson Cancer Center, Baylor College of Medicine,